Skip to main content
      RT @doctorRBC: IVIG pending FDA review for tx of dermatomyositis after ProDERM study. Do you use IVIG for tx of DM?
      #EUL

      Robert B Chao, MD doctorRBC

      4 years 5 months ago
      IVIG pending FDA review for tx of dermatomyositis after ProDERM study. Do you use IVIG for tx of DM? #EULAR2021 @RheumNow
      RT @doctorRBC: ProDERM RCT IVIG in Dermatomyositis
      ⭐️improved TIS scores compared to pbo
      ⭐️common AE: headaches

      Robert B Chao, MD doctorRBC

      4 years 5 months ago
      ProDERM RCT IVIG in Dermatomyositis ⭐️improved TIS scores compared to pbo ⭐️common AE: headaches, pyrexia, nausea ⭐️serious AE: PE, CVA, DVT ⭐️approved in Europe, pending FDA Abs#OP0008 #EULAR2021 @RheumNow
      RT @doctorRBC: Comparison of disease activity and PROs in AxSpA vs. AxPsA
      ⭐️AxSpA ⬆️ uveitis and IBD
      ⭐️AxPsA

      Robert B Chao, MD doctorRBC

      4 years 5 months ago
      Comparison of disease activity and PROs in AxSpA vs. AxPsA ⭐️AxSpA ⬆️ uveitis and IBD ⭐️AxPsA ⬆️enthesitis and dactylitis ⭐️AxSpA pts ⬆️pain, spinal pain PROs ⭐️Fatigue and work impairment did not differ in AxSpA vs AxPsA Abs#OP0049 #EULAR2021 @RheumNow https://t.co/wGD6IA5ahb
      RT @zach_wallace_md: ⁦@jeffsparks⁩ knocking it out of the park presenting our findings on b/tsDMARD associations wit

      Zach Wallace zach_wallace_md

      4 years 5 months ago
      ⁦@jeffsparks⁩ knocking it out of the park presenting our findings on b/tsDMARD associations with COVID-19 outcomes ⁦@eular_org⁩ ⁦@EULAR_Press⁩ check out our full paper just published in ⁦@ARD_BMJ⁩ https://t.co/jcA1LN45R3
      RT @RichardPAConway: Dr Palomäki on influence of MUC5B promotor variant on ILD risk in RA and non-RA. Lifetime risk ILD

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Palomäki on influence of MUC5B promotor variant on ILD risk in RA and non-RA. Lifetime risk ILD 14.5% for RA+MUC5B+, 5.2% for RA+MUC5B-, 3.9% RA-MUC5B+ 1.3% RA-MUC5B- @RheumNow #EULAR2021 Abstr#OP0007 https://t.co/BnexQE1Pw9
      RT @RichardPAConway: Dr Ponte presenting on use of halo sign on TA US to monitor GCA disease activity. Seems good, prese

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Ponte presenting on use of halo sign on TA US to monitor GCA disease activity. Seems good, present and increased in 16/17 (94.1%) cases of first disease relapse @RheumNow #EULAR2021 #AbstrOP0055 https://t.co/T6hKjkb4AT
      RT @ejdein1: Abs#OP0009 presents 8 min web-based video for COVID vax education sent via text message. 76% more likely to

      Eric Dein ejdein1

      4 years 5 months ago
      Abs#OP0009 presents 8 min web-based video for COVID vax education sent via text message. 76% more likely to get vax. #EULAR2021. @RheumNow. Pts need to hear from their rheumatologists our thoughts on vax, ideally in person, but phone is great outreach https://t.co/aimGBufYpe
      RT @ejdein1: Excellent job by @jeffsparks @zach_wallace_md @rheum_covid on Abs#0P0006 at #EULAR2021.
      ⭐️RTX and JAKi:

      Eric Dein ejdein1

      4 years 5 months ago
      Excellent job by @jeffsparks @zach_wallace_md @rheum_covid on Abs#0P0006 at #EULAR2021. ⭐️RTX and JAKi: increased COVID severity, not seen in IL-6 or ABA. Critical findings, but confounding role of co-morbidities/ILD/cancer, esp in RTX patients? @RheumNow
      RT @ejdein1: Dr. Tani: Who has trouble tapering below 5mg/d prednisone in SLE
      ☑️Older patients
      ☑️High disease ac

      Eric Dein ejdein1

      4 years 5 months ago
      Dr. Tani: Who has trouble tapering below 5mg/d prednisone in SLE ☑️Older patients ☑️High disease activity ☑️Skin and MSK manifestations ☑️Pts treated before 2000. Try to avoid long-term steroid usage early in the disease course, as it gets harder over time. #EULAR2021, @RheumNow
      RT @doctorRBC: Excellent talk by @LCalabreseDO on the balance of the immune response!
      ⭐️Exhausted T cells seen in rh

      Robert B Chao, MD doctorRBC

      4 years 5 months ago
      Excellent talk by @LCalabreseDO on the balance of the immune response! ⭐️Exhausted T cells seen in rheumatic dz, chronic infections, cancers, severe COVID-19 ⭐️CPI for treatment of latent infections? CPI for treatment of COVID? 🤔 Abs#OP7137 #EULAR2021 @RheumNow https://t.co/18rvFkpPTx
      RT @doctorRBC: Secukinumab effective in AS patients, irrespective of gender
      AQUILA 52 week study
      ⭐️improvement in BA

      Robert B Chao, MD doctorRBC

      4 years 5 months ago
      Secukinumab effective in AS patients, irrespective of gender AQUILA 52 week study ⭐️improvement in BASDAI, PGA, severity of depressive mood in both men and women ⭐️women had overall higher disease burden in global functioning and depressive mood POS0899 #EULAR2021 @RheumNow
      RT @RichardPAConway: Dr Atienza-Mateo presents abstract #POS0595 on abatacept in RA-ILD. Abatacept surprisingly appeared

      Richard Conway RichardPAConway

      4 years 5 months ago
      Dr Atienza-Mateo presents abstract #POS0595 on abatacept in RA-ILD. Abatacept surprisingly appeared to be equally good in stabilising FVC and DLCO in both UIP and NSIP patterns in RA-ILD. @RheumNow #EULAR2021 Abstr#POS0595 https://t.co/kHUxWXnaBG
      RT @RichardPAConway: I'm presenting data on COVID-19 in Irish rheumatic disease patients. Age, number comorbidities, glu

      Richard Conway RichardPAConway

      4 years 5 months ago
      I'm presenting data on COVID-19 in Irish rheumatic disease patients. Age, number comorbidities, glucocorticoids, associated increased hospitalisation. Inflammatory arthritis associated decreased hospitalisation. @RheumNow #EULAR2021 #AbstrPOS1162 https://t.co/0gKxiMNYTf
      RT @ejdein1: #EULAR2021 recommendations: RMDs face no more risk of contracting COVID-19, no current evidence of worse pr

      Eric Dein ejdein1

      4 years 5 months ago
      #EULAR2021 recommendations: RMDs face no more risk of contracting COVID-19, no current evidence of worse prognosis. Do you tell patients similar stats? @RheumNow
      RT @ejdein1: #EULAR2021 recommendations on mgmt of RMD in COVID: continue treatment if symptom free, steroids at lowest

      Eric Dein ejdein1

      4 years 5 months ago
      #EULAR2021 recommendations on mgmt of RMD in COVID: continue treatment if symptom free, steroids at lowest dose. @Rheumnow. https://t.co/U5zr7EHvTv
      ×